Target Group Inc (CBDY)
0.0058
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Target Group Shareholders Equity (Quarterly): -6.973M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.973M |
| September 30, 2023 | -6.855M |
| June 30, 2023 | -6.567M |
| March 31, 2023 | -7.308M |
| December 31, 2022 | -6.560M |
| September 30, 2022 | -2.783M |
| June 30, 2022 | -2.481M |
| March 31, 2022 | -2.702M |
| December 31, 2021 | -2.152M |
| September 30, 2021 | -2.105M |
| June 30, 2021 | -4.237M |
| March 31, 2021 | -5.267M |
| December 31, 2020 | -3.521M |
| September 30, 2020 | 1.727M |
| June 30, 2020 | 5.204M |
| March 31, 2020 | 5.815M |
| December 31, 2019 | 3.789M |
| September 30, 2019 | 14.63M |
| June 30, 2019 | 14.59M |
| March 31, 2019 | 11.09M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.344M |
| September 30, 2018 | 1.436M |
| June 30, 2018 | -1.823M |
| March 31, 2018 | -1.665M |
| December 31, 2017 | -2.062M |
| September 30, 2017 | -1.754M |
| June 30, 2017 | -1.636M |
| March 31, 2017 | -2.207M |
| December 31, 2016 | -1.820M |
| September 30, 2016 | -1.720M |
| June 30, 2016 | -1.193M |
| March 31, 2016 | -0.906M |
| December 31, 2015 | -1.088M |
| September 30, 2015 | -0.7103M |
| June 30, 2015 | -0.5028M |
| March 31, 2015 | -0.3883M |
| December 31, 2014 | -0.2786M |
| September 30, 2014 | -0.0383M |
| June 30, 2014 | -0.001M |
| March 31, 2014 | 0.0008M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-7.308M
Minimum
Mar 2023
14.63M
Maximum
Sep 2019
-0.7239M
Average
-2.702M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.841M |
| Total Liabilities (Quarterly) | 15.81M |
| Debt to Equity Ratio | -0.0001 |
| Current Ratio | 0.2121 |